PAHC's liquidation posture as of March 31, 2026 remains deeply negative, consistent with MFFAIS CLV of approximately -$867M and LLV of approximately -$646M. The balance sheet carries $1.445B in total assets against $1.083B in total liabilities, yielding GAAP book equity of $362M. Under liquidation haircuts, however, recoverable asset value collapses materially. Cash and short-term investments of $77.5M recover near par. Accounts receivable of $222M at 90-95% haircut yields approximately $199-210M. Inventory of $540M is the single largest current asset and at a 60% recovery rate yields approximately $324M — but the nine-month operating period consumed $92.5M of inventory build, suggesting elevated carrying values relative to near-term turnover. PP&E net book value of $359M at 50-70% recovery yields approximately $180-251M. The intangible stack — $31.7M finite-lived intangibles, $59.9M goodwill, plus additional acquisition-related embedded step-up values — is zeroed under the lens. The total gross term debt carrying amount is $626M (current $22.8M plus non-current $598M), with $115M outstanding on the revolving facility also included in the $621M long-term debt figure. On April 28, 2026, PAHC expanded the revolver by $125M to $435M total capacity — a post-period event that increases the available liability stack in a wind-up scenario without adding tangible recoverable assets. Operating lease obligations total approximately $52M ($9.4M current, $42.5M non-current) and must be settled at face value in liquidation. The environmental accrual of $4.2M is a minimum floor; actual wind-up environmental remediation liabilities for a multi-site pharmaceutical manufacturer would likely exceed this figure materially. The MFA portfolio acquisition from Zoetis (closed October 31, 2024) drove $156.8M in incremental nine-month revenues and added significant acquired PP&E subject to step-up depreciation ($5.0M over nine months) and intangible amortization. The acquisition-related cost structure increases both the tangible PP&E base and the intangible stack (zeroed under the lens), making the liquidation-vs.-going-concern divergence wider post-acquisition. Nine-month operating cash generation of $44.9M versus $58.9M in the prior comparable period reflects $92.5M of inventory accumulation — a use of cash that inflates the balance sheet at a haircut-subject rate. The filing does not separately disclose undrawn letters of credit or environmental indemnification exposure beyond the $4.2M accrual, both of which are contingent liabilities that could further erode recovery. Working capital (as company-defined, excluding cash and current debt) expanded to $558M from $456M at June 30, 2025, driven primarily by the inventory build. Under the liquidation lens, this working capital expansion represents incremental haircut exposure, not recoverable value enhancement.
▼ Community Notes